Win Advisors’s Clorox CLX Stock Holding History

Win Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-855	Closed	-$123K	–	127
2022 Q2	$123K	Buy	855 +839	+5,244%	+$120K	0.24%	25
2022 Q1	$2K	Buy	+16	New	+$2.45K	﹤0.01%	183

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Win Advisors's CLX Position: Q3 2022 in Review

Win Advisors sold out of Clorox (CLX) in Q3 2022, closing a stake of 855 shares — an estimated $123K sold.

Win Advisors first reported a position in CLX in Q1 2022 and held it in 2 quarters. The position peaked at $123K in Q2 2022. 1,045 funds tracked by Wall St. Rank hold CLX as of Q3 2022.

Win Advisors reported no remaining Clorox position as of Q3 2022 after selling out during the quarter.
Win Advisors sold 855 Clorox shares in Q3 2022, an estimated $123K.
Win Advisors first reported a position in Clorox in Q1 2022 and held it in 2 quarters.
Win Advisors's Clorox position peaked at $123K in Q2 2022.
1,045 funds tracked by Wall St. Rank held Clorox as of Q3 2022.

Based on Win Advisors's 13F filing for Q3 2022, filed 27 Oct 2022.